Why Oral GLP-1 Drugs Could Change Diabetes Care
GLP-1 medications are currently the talk of the town. If you live with type 2 diabetes, you've probably heard a lot about these and…
Do you have obesity, with or without Type 2 Diabetes?
You may qualify for a research study evaluating an investigational medication for weight management.
This study is designed to understand how well and how safely two doses of CagriSema help people manage their weight when combined with a lower calorie diet and increased physical activity.
Participants will receive a weekly dose of either the study medication or a comparator medication (Semaglutide). Visits include a combination of in-person and phone appointments.
To take part in the study, participants should:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator